Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 23
Phase 46

Trial Status

Completed11
Recruiting3
Terminated2
Other2

Role Distribution

Principal Investigator18
PI Rate100%

Activity Timeline

Clinical Trials (18)

NCT07185399Phase 4Active Not Recruiting
Systems Biological Analysis of Immune Responses to RSV Vaccine
Respiratory Syncytial Virus (RSV)
PrincipalinvestigatorStart date: 2025-10-13
NCT06753474Phase 1Recruiting
A/Texas Flu Challenge
Influenza
PrincipalinvestigatorStart date: 2025-02-04
NCT06100913Phase 2Active Not Recruiting
Immunology of Ebola Vaccine
Ebola Virus Disease
PrincipalinvestigatorStart date: 2024-08-06
NCT06024096Phase 4Completed
Systems Biological Assessment of Statin Effect on Vaccine Responses
Vaccine Response
PrincipalinvestigatorStart date: 2023-09-20
NCT05870839Phase 1Completed
Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States
SARS-CoVSARS-CoV-2
PrincipalinvestigatorStart date: 2023-05-11
NCT05801978Phase 4Recruiting
Durability of Vaccine Responses
Vaccine Response
PrincipalinvestigatorStart date: 2023-04-11
NCT05332899Phase 1Recruiting
Influenza Human Challenge Model
Influenza
PrincipalinvestigatorStart date: 2022-05-24
NCT03993717Terminated
Solid Organ Transplant SHINGRIX
Kidney Transplant; Complications
PrincipalinvestigatorStart date: 2020-01-30
NCT04047979Phase 2Completed
Systems Biology of Zoster Vaccine
Chicken PoxShinglesZoster+1 more
PrincipalinvestigatorStart date: 2019-11-14

Showing 10 of 18 trials

Research Network

Collaboration Network

7 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Angela Branche, MD

University of Rochester

Moderately Similar
2 trials

Shared therapeutic areas:

Influenza, HumanSARS-CoVSARS-CoV-2

Worked with same sponsors:

Vaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and Company
Collaborated on 1 trial
Similarity Score34%

Justin Ortiz, MD, MS

University of Maryland

Related
1 trials

Shared therapeutic areas:

SARS-CoVSARS-CoV-2

Worked with same sponsors:

Vaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and Company
Collaborated on 1 trial
Similarity Score24%

Varun Phadke, MD

Emory University

Related
1 trials

Shared therapeutic areas:

Vaccine Response

Worked with same sponsors:

Emory University
Collaborated on 1 trial
Similarity Score14%

Vin Tangpricha, MD, PhD

Emory University

Related
5 trials

Shared therapeutic areas:

Vaccine Response

Worked with same sponsors:

Emory University
Collaborated on 1 trial
Similarity Score14%

Daniel S. Graciaa, MD, MPH, MSc

Emory University

Related
1 trials

Shared therapeutic areas:

Vaccine Response

Worked with same sponsors:

Emory University
Collaborated on 1 trial
Similarity Score14%

Ali Ellebedy, PhD

Washington University School of Medicine

Related
2 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola

Worked with same sponsors:

Emory UniversityMerck Sharp & Dohme LLC+1 more
Collaborated on 1 trial
Similarity Score14%

Matthew J Memoli, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
15 trials

Shared therapeutic areas:

Influenza, HumanSARS-CoV-2

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Similarity Score4%

Veryl Hodges, DO

Clopton Clinic

Related
1 trials

Shared therapeutic areas:

Influenza, Human
Similarity Score2%

Shaukat A. Shah, MD

St. Joseph's Medical Associates, Stockton, CA 95204

Related
1 trials

Shared therapeutic areas:

Influenza, Human
Similarity Score2%

Keith S. Reisinger, MD, MPH

Primary Physicians Research, Inc

Related
1 trials

Shared therapeutic areas:

Influenza, Human
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (18)

Showing 18 of 18 trials

NCT07185399Phase 4PrincipalInvestigator

Systems Biological Analysis of Immune Responses to RSV Vaccine

Respiratory Syncytial Virus (RSV)
Active Not Recruiting
NCT06753474Phase 1PrincipalInvestigator

A/Texas Flu Challenge

Influenza
Recruiting
NCT06100913Phase 2PrincipalInvestigator

Immunology of Ebola Vaccine

Ebola Virus Disease
Active Not Recruiting
NCT06024096Phase 4PrincipalInvestigator

Systems Biological Assessment of Statin Effect on Vaccine Responses

Vaccine Response
Completed
NCT05870839Phase 1PrincipalInvestigator

Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States

SARS-CoVSARS-CoV-2
Completed
NCT05801978Phase 4PrincipalInvestigator

Durability of Vaccine Responses

Vaccine Response
Recruiting
NCT05332899Phase 1PrincipalInvestigator

Influenza Human Challenge Model

Influenza
Recruiting
NCT03993717PrincipalInvestigator

Solid Organ Transplant SHINGRIX

Kidney Transplant; Complications
Terminated
NCT04047979Phase 2PrincipalInvestigator

Systems Biology of Zoster Vaccine

Chicken PoxShinglesZoster+1 more
Completed
NCT03686514Phase 4PrincipalInvestigator

The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics

Influenza
Terminated
NCT03701061Phase 4PrincipalInvestigator

Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response

Influenza A Subtype H5N1 Infection
Completed
NCT03557008Phase 4PrincipalInvestigator

Responses to Rabies Vaccine in Adults With or Without Antibiotics

Rabies Human
Completed
NCT03251495Phase 2PrincipalInvestigator

Immunologic Responses to a Live Attenuated Oral Cholera Vaccine

Cholera
Completed
NCT01307449Not ApplicablePrincipalInvestigator

Systems Biology of PNEUMOVAX®23 and PREVNAR 13®

Pneumococcal Infection
Completed
NCT01232868Not ApplicablePrincipalInvestigator

Systems Biology of Trivalent Influenza Vaccine (TIV) in Young and Elderly

Influenza
Completed
NCT01331161Not ApplicablePrincipalInvestigator

Systems Biology of Zoster Vaccine (ZOSTAVAX®) in Young and Elderly

Shingles
Completed
NCT02154061Not ApplicablePrincipalInvestigator

Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics

Influenza
Completed
NCT02438423Phase 1PrincipalInvestigator

Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle

Influenza
Completed

All 18 trials loaded